Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Stifel

This SpaceX Rival Is Soaring on a New Multibillion-Dollar Opportunity. Should You Buy the Stock Now?

Rocket Lab has secured multibillion-dollar hypersonic contracts from the U.S. and the U.K. Is it reason enough to load up on RKLB shares today?

Barchart

Intel’s New CEO Is Talking the Talk and Winning Over Analysts. Should You Buy INTC Stock Now?

Down over 70% from record highs, Intel is a tech stock that trades at a discount to consensus price target estimates in April 2025.

Barchart

Analysts Say the ‘Anti Elon Musk Crowd’ Will Hurt Tesla in the ‘Near Term.’ Should You Buy or Sell TSLA Stock Here?

Tesla's stock has dropped nearly 40% year-to-date, sparking debate among analysts, as the company faces challenges from protesters and market volatility.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Tesla Stock Plunged 34% in Q1. Should You Buy the Dip or Stay Away From Shares Here?

Tesla stock’s Q1 performance was its worst in about three years. But there’s reason to hold on to TSLA shares.

Barchart

Elon Musk Loses a Billion Dollars Every Time the Tesla Stock Drops by $2.43

A growing negative sentiment around Tesla is driving a mass exodus of customers to rival EV brands, including BYD and Lucid Motors.

International Business Times UK

Stifel: Ignore the Trump Panic and Buy These 3 Cruise Stocks on the Dip

Analysts at Stifel see the recent cruise stocks selloff as an overblown reaction and advise investors to buy these three stocks on the dip.

Barchart

Elon Musk’s net worth falls below $400 billion for the first time this year after Tesla’s 27% stock avalanche the last two months

Tesla had its worst year in more than a decade, reporting a 1.1% year-over-year sales loss for 2024.

Fortune

Read news from The Economist, FT, and more,
with one subscription

Procter & Gamble Stock Rises on Earnings Beat: What to Know

Procter & Gamble is trading near the top of the Dow Wednesday after the consumer staples giant beat expectations for its fiscal 2025 second quarter.

Kiplinger

Nvidia CES 2025 Updates: What Investors Need to Know

Nvidia stock is the worst Dow Jones stock Tuesday after the AI bellwether made several announcements at CES 2025. Here's what you need to know.

Kiplinger

What's in Store for the Bull Market in 2025?

The current bull market recently turned two and most – but not all – Wall Street pros expect the party to continue in the new year.

Kiplinger

Truist Analysts Love This Dividend Stock With a 15% Yield

Truist analysts are bullish on Mach Natural Resources (MNR), a new energy stock offering a 15% dividend yield and 45.5% upside potential.

Barchart

Jabil Stock Pops After a Beat-And-Raise Quarter

Jabil stock is higher Wednesday after the electronics firm beat earnings expectations and raised its full-year outlook. Here's what you need to know.

Kiplinger

Is Micron Stock a Buy, Sell, or Hold Before December 18?

With Micron Technology's Q1 earnings release on the horizon, should investors grab a slice of the shares or let the earnings guide the next move?

Barchart

Lululemon's Strong Earnings and Share Buyback Push Analysts to Increase Price Forecast

Analysts raise Lululemon's price targets, citing strong Q3 results, international growth, product innovation, and future expansion opportunities.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Kiplinger

Why Hewlett Packard Stock Is Still a Buy After Earnings

Hewlett Packard stock is sizzling Friday after the tech giant beat expectations for its fiscal fourth quarter. Here's what Wall Street is saying.

Benzinga

ChargePoint Q3 Results Some Restructuring Benefits, Analysts Say: Expect 'Return To Growth In 2025'

ChargePoint's Q3 results beat expectations, but gross margins were impacted by one-time charges. Analysts expect a return to growth in 2025.

Benzinga

Marvell Technology Posts Solid Q3 Beat: Analysts Raise Forecasts, Expect 40%-50% Earnings Growth

Marvell Technology reported upbeat earnings amid exciting earnings season. Analysts raised their price targets, expecting strong growth.

Benzinga

AT&T To Rally Around 14%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Zscaler Posts Q1 Beat: 8 Analysts Express Concern Around CFO Retirement, Guidance

Zscaler shares tanked despite upbeat Q1 results. The company raised its fiscal-year guidance and announced the departure of its CFO.

Benzinga

Starbucks To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Kiplinger

What's Behind Starbucks Stock's New Sell Rating?

Starbucks stock has rallied hard since Brian Niccol was tapped as the coffee chain's new CEO, but one analyst thinks turnaround plans will be costly.

Kiplinger

Qualcomm Stock Is Still a Buy After Earnings, Buyback News

Qualcomm stock is higher Thursday after the tech giant beat earnings and unveiled a big stock buyback program. Here's what Wall Street is saying.

Kiplinger

Amazon Leads Dow Jones Stocks After Stellar Earnings Report

Amazon stock is higher Friday after the e-commerce and cloud giant reported strong Q3 earnings and Wall Street sees even more upside ahead. Here's why.

Barchart

Up 45% YTD, Should You Buy This Outperforming Healthcare Stock?

Boston Scientific shows impressive growth in Q3 results, garnering bullish analyst support despite clinical trial setbacks.

Kiplinger

IBM Stock Takes a Rare Tumble After Earnings: What to Know

IBM stock is chipping away at its impressive year-to-date return after a Q3 revenue miss, but one analyst isn't worried. Here's why.

1 … 4 5 6 7

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.